SMA Europe is pleased to announce the results of its fourth international Call for SMA Research Projects.
Grant recipients 2011
SMA Europe is pleased to announce the award of about € 680,000 for research into Spinal Muscular Atrophy – SMA, in response to its Call for Research Projects 2011.
The six institutions which attracted support are:
• University of Oxford,UK : Professor Matthew Wood (“Exosome delivery of splice switching oligonucleotides for the treatment of SMA”)
• Columbia University, New-York, USA : Professor Umrao Monani (“Investigating novel genetic determinants of the SMA phenotype”)
• Catholic University of Leuven, Belgium : Professor Tilmann Achsel (“mRNA transport in SMA pathogenesis”)
• University Hospital of Cologne, Germany : post-doctoral fellow Dr Riessland Markus (“SMA: Molecular and functional analysis of a New modifier of SMA”)
• University of Valencia, Spain : post-doctoral fellow Dr Amparo Garcia –Lopez (“New approaches to drug discovery in SMA: using RNA secondary structure as a new therapeutic target”)
• Faculté de Médecine et Pharmacie, Rouen, France : Post-doctoral fellow Dr Kathleen Mahias (“Evaluation of the contribution of SMN1 and SMN2 sequence variants to the clinical severity of SMA”)
Grant recipients 2010-2008
Grant recipients 2010
SMA Europe is pleased to announce the award of about €400,000 for research into Spinal Muscular Atrophy – SMA, in response to its Call for Research Projects 2010.
The four institutions which attracted support are:
• Hopital de la Salpétrière, Paris, France: Dr Martine Barkats (“AAV9-mediated gene therapy in murine models of SMA”)
• University of Manchester, UK: Professor David Satelle (“New drugs and new drug targets for Spinal Muscular Atrophy using chemical and functional genomics”)
• The Ohio state University, Columbus, USA: post-doctoral fellow Dr Sandra Duque (“Delivery and correction of SMA using AAV vectors”)
• Faculté de Médecine et Pharmacie, Rouen, France: Post-doctoral fellow Dr. Kathleen Mahias (“Evaluation of the contribution of SMN1 and SMN2 sequence variants to the clinical severity of SMA”)
Grant recipients 2009
SMA Europe is pleased to announce the award of about €650,000 for research into Spinal Muscular Atrophy – SMA, in response to its Call for Research Projects 2009.
The seven institutions which attracted support are:
• Columbia Univerity, New York, USA: Professor Umrao Monani
• Molecular Genetics Institute of Montpellier, France: Professor Rémy Bordonne
• The University of Sheffield, UK: Professors Ke Ning and Mimoun Azzouz
• University of Western Australia, Australia: Professor Steve Wilton
• University of Bern, Switzerland: post-doctoral fellow Dr Rachel Nlend Nlend
• INSERM, Université de Nantes, France: post-doctoral fellow Dr Beatrice Joussemet
• Emory University, Atlanta, USA: post-doctoral fellow Dr Claudia Fallini
Grant recipients 2008
SMA Europe is pleased to announce the award of over €750,000 for research into Spinal Muscular Atrophy – SMA, in response to its Call for Research Projects 2008.
The five institutions which attracted support are:
• University of Lisbon: Professor Margarida Gama Carvalho (“Characterization of post-transcriptional control mechanisms regulating SMN2 gene expression.”)
• Università Cattolica, Rome: Professor Eugenio Mercuri (“Outcome measures in SMA types II and III”)
• University of Milan: Professor Giacomo Comi (cofunded with FSMA) (“Development of a stem cell approach for treating Spinal Muscular Atrophy”)
• Institut de Myologie, Paris: Dr Martine Barkats (“Evaluation of AAV-mediated gene therapy in murine and feline SMA models”)
• University of Missouri, USA: post-doctoral fellow Dr Monir Shababi (“A Two-Pronged Approach to Develop a Treatment for Spinal Muscular Atrophy”)
The AFM scientific council
The AFM scientific council is composed of volunteer scientists and doctors who are recognised experts in their fields. Its role is to evaluate the scientific content of projects submitted to the AFM and to advise the Board of Directors, who makes the final decision. It also proposes possible research themes and makes a priori and a posteriori evaluations of the scientific quality of the projects. In particular, it advises during the evaluation of projects following Calls for Proposals.
